Effect of inadequate adherence on clinical outcomes: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort
Anti-tumour necrosis factor (TNF) therapy has revolutionised patient prognosis in rheumatoid arthritis. In the UK, continuing anti-TNF therapy requires a sustained response as determined by the disease activity score in 28 joints (DAS28). Adherence to disease modifying anti-rheumatic drugs (DMARDs)...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Bluett, James [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2014 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Effects of shape functions on flexural–torsional buckling of fixed circular arches - Dou, Chao ELSEVIER, 2013, London [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:383 ; year:2014 ; day:26 ; month:02 ; pages:26 |
| Links: |
|---|
| DOI / URN: |
10.1016/S0140-6736(14)60289-0 |
|---|
| Katalog-ID: |
ELV022395334 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV022395334 | ||
| 003 | DE-627 | ||
| 005 | 20230623163825.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S0140-6736(14)60289-0 |2 doi | |
| 028 | 5 | 2 | |a GBVA2014002000011.pica |
| 035 | |a (DE-627)ELV022395334 | ||
| 035 | |a (ELSEVIER)S0140-6736(14)60289-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 690 |q VZ |
| 084 | |a 38.38 |2 bkl | ||
| 084 | |a 56.20 |2 bkl | ||
| 084 | |a 56.11 |2 bkl | ||
| 100 | 1 | |a Bluett, James |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Effect of inadequate adherence on clinical outcomes: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort |
| 264 | 1 | |c 2014 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Anti-tumour necrosis factor (TNF) therapy has revolutionised patient prognosis in rheumatoid arthritis. In the UK, continuing anti-TNF therapy requires a sustained response as determined by the disease activity score in 28 joints (DAS28). Adherence to disease modifying anti-rheumatic drugs (DMARDs) is low but little is known about adherence to biological therapies and its association to treatment response. We investigated the association of adherence to subcutaneous anti-TNF therapy and DAS28 in people with rheumatoid arthritis. | ||
| 700 | 1 | |a Morgan, Catharine |4 oth | |
| 700 | 1 | |a Thurston, Layla |4 oth | |
| 700 | 1 | |a Plant, Darren |4 oth | |
| 700 | 1 | |a Morgan, Ann |4 oth | |
| 700 | 1 | |a Wilson, Anthony |4 oth | |
| 700 | 1 | |a Isaacs, John |4 oth | |
| 700 | 1 | |a Hyrich, Kimme |4 oth | |
| 700 | 1 | |a Cordingley, Lis |4 oth | |
| 700 | 1 | |a Barton, Anne |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Dou, Chao ELSEVIER |t Effects of shape functions on flexural–torsional buckling of fixed circular arches |d 2013 |g London [u.a.] |w (DE-627)ELV007685041 |
| 773 | 1 | 8 | |g volume:383 |g year:2014 |g day:26 |g month:02 |g pages:26 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/S0140-6736(14)60289-0 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OPC-GEO | ||
| 936 | b | k | |a 38.38 |j Seismologie |q VZ |
| 936 | b | k | |a 56.20 |j Ingenieurgeologie |j Bodenmechanik |q VZ |
| 936 | b | k | |a 56.11 |j Baukonstruktion |q VZ |
| 951 | |a AR | ||
| 952 | |d 383 |j 2014 |b 26 |c 0226 |h 26 |y 383.2014, S26- | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
j b jb |
|---|---|
| matchkey_str |
bluettjamesmorgancatharinethurstonlaylap:2014----:fetfndqaedeecociiaotoerslsrmhbooisnhuaodrhiigntc |
| hierarchy_sort_str |
2014 |
| bklnumber |
38.38 56.20 56.11 |
| publishDate |
2014 |
| allfields |
10.1016/S0140-6736(14)60289-0 doi GBVA2014002000011.pica (DE-627)ELV022395334 (ELSEVIER)S0140-6736(14)60289-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 VZ 38.38 bkl 56.20 bkl 56.11 bkl Bluett, James verfasserin aut Effect of inadequate adherence on clinical outcomes: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort 2014 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Anti-tumour necrosis factor (TNF) therapy has revolutionised patient prognosis in rheumatoid arthritis. In the UK, continuing anti-TNF therapy requires a sustained response as determined by the disease activity score in 28 joints (DAS28). Adherence to disease modifying anti-rheumatic drugs (DMARDs) is low but little is known about adherence to biological therapies and its association to treatment response. We investigated the association of adherence to subcutaneous anti-TNF therapy and DAS28 in people with rheumatoid arthritis. Morgan, Catharine oth Thurston, Layla oth Plant, Darren oth Morgan, Ann oth Wilson, Anthony oth Isaacs, John oth Hyrich, Kimme oth Cordingley, Lis oth Barton, Anne oth Enthalten in Elsevier Dou, Chao ELSEVIER Effects of shape functions on flexural–torsional buckling of fixed circular arches 2013 London [u.a.] (DE-627)ELV007685041 volume:383 year:2014 day:26 month:02 pages:26 https://doi.org/10.1016/S0140-6736(14)60289-0 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GEO 38.38 Seismologie VZ 56.20 Ingenieurgeologie Bodenmechanik VZ 56.11 Baukonstruktion VZ AR 383 2014 26 0226 26 383.2014, S26- 045F 610 |
| spelling |
10.1016/S0140-6736(14)60289-0 doi GBVA2014002000011.pica (DE-627)ELV022395334 (ELSEVIER)S0140-6736(14)60289-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 VZ 38.38 bkl 56.20 bkl 56.11 bkl Bluett, James verfasserin aut Effect of inadequate adherence on clinical outcomes: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort 2014 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Anti-tumour necrosis factor (TNF) therapy has revolutionised patient prognosis in rheumatoid arthritis. In the UK, continuing anti-TNF therapy requires a sustained response as determined by the disease activity score in 28 joints (DAS28). Adherence to disease modifying anti-rheumatic drugs (DMARDs) is low but little is known about adherence to biological therapies and its association to treatment response. We investigated the association of adherence to subcutaneous anti-TNF therapy and DAS28 in people with rheumatoid arthritis. Morgan, Catharine oth Thurston, Layla oth Plant, Darren oth Morgan, Ann oth Wilson, Anthony oth Isaacs, John oth Hyrich, Kimme oth Cordingley, Lis oth Barton, Anne oth Enthalten in Elsevier Dou, Chao ELSEVIER Effects of shape functions on flexural–torsional buckling of fixed circular arches 2013 London [u.a.] (DE-627)ELV007685041 volume:383 year:2014 day:26 month:02 pages:26 https://doi.org/10.1016/S0140-6736(14)60289-0 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GEO 38.38 Seismologie VZ 56.20 Ingenieurgeologie Bodenmechanik VZ 56.11 Baukonstruktion VZ AR 383 2014 26 0226 26 383.2014, S26- 045F 610 |
| allfields_unstemmed |
10.1016/S0140-6736(14)60289-0 doi GBVA2014002000011.pica (DE-627)ELV022395334 (ELSEVIER)S0140-6736(14)60289-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 VZ 38.38 bkl 56.20 bkl 56.11 bkl Bluett, James verfasserin aut Effect of inadequate adherence on clinical outcomes: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort 2014 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Anti-tumour necrosis factor (TNF) therapy has revolutionised patient prognosis in rheumatoid arthritis. In the UK, continuing anti-TNF therapy requires a sustained response as determined by the disease activity score in 28 joints (DAS28). Adherence to disease modifying anti-rheumatic drugs (DMARDs) is low but little is known about adherence to biological therapies and its association to treatment response. We investigated the association of adherence to subcutaneous anti-TNF therapy and DAS28 in people with rheumatoid arthritis. Morgan, Catharine oth Thurston, Layla oth Plant, Darren oth Morgan, Ann oth Wilson, Anthony oth Isaacs, John oth Hyrich, Kimme oth Cordingley, Lis oth Barton, Anne oth Enthalten in Elsevier Dou, Chao ELSEVIER Effects of shape functions on flexural–torsional buckling of fixed circular arches 2013 London [u.a.] (DE-627)ELV007685041 volume:383 year:2014 day:26 month:02 pages:26 https://doi.org/10.1016/S0140-6736(14)60289-0 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GEO 38.38 Seismologie VZ 56.20 Ingenieurgeologie Bodenmechanik VZ 56.11 Baukonstruktion VZ AR 383 2014 26 0226 26 383.2014, S26- 045F 610 |
| allfieldsGer |
10.1016/S0140-6736(14)60289-0 doi GBVA2014002000011.pica (DE-627)ELV022395334 (ELSEVIER)S0140-6736(14)60289-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 VZ 38.38 bkl 56.20 bkl 56.11 bkl Bluett, James verfasserin aut Effect of inadequate adherence on clinical outcomes: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort 2014 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Anti-tumour necrosis factor (TNF) therapy has revolutionised patient prognosis in rheumatoid arthritis. In the UK, continuing anti-TNF therapy requires a sustained response as determined by the disease activity score in 28 joints (DAS28). Adherence to disease modifying anti-rheumatic drugs (DMARDs) is low but little is known about adherence to biological therapies and its association to treatment response. We investigated the association of adherence to subcutaneous anti-TNF therapy and DAS28 in people with rheumatoid arthritis. Morgan, Catharine oth Thurston, Layla oth Plant, Darren oth Morgan, Ann oth Wilson, Anthony oth Isaacs, John oth Hyrich, Kimme oth Cordingley, Lis oth Barton, Anne oth Enthalten in Elsevier Dou, Chao ELSEVIER Effects of shape functions on flexural–torsional buckling of fixed circular arches 2013 London [u.a.] (DE-627)ELV007685041 volume:383 year:2014 day:26 month:02 pages:26 https://doi.org/10.1016/S0140-6736(14)60289-0 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GEO 38.38 Seismologie VZ 56.20 Ingenieurgeologie Bodenmechanik VZ 56.11 Baukonstruktion VZ AR 383 2014 26 0226 26 383.2014, S26- 045F 610 |
| allfieldsSound |
10.1016/S0140-6736(14)60289-0 doi GBVA2014002000011.pica (DE-627)ELV022395334 (ELSEVIER)S0140-6736(14)60289-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 VZ 38.38 bkl 56.20 bkl 56.11 bkl Bluett, James verfasserin aut Effect of inadequate adherence on clinical outcomes: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort 2014 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Anti-tumour necrosis factor (TNF) therapy has revolutionised patient prognosis in rheumatoid arthritis. In the UK, continuing anti-TNF therapy requires a sustained response as determined by the disease activity score in 28 joints (DAS28). Adherence to disease modifying anti-rheumatic drugs (DMARDs) is low but little is known about adherence to biological therapies and its association to treatment response. We investigated the association of adherence to subcutaneous anti-TNF therapy and DAS28 in people with rheumatoid arthritis. Morgan, Catharine oth Thurston, Layla oth Plant, Darren oth Morgan, Ann oth Wilson, Anthony oth Isaacs, John oth Hyrich, Kimme oth Cordingley, Lis oth Barton, Anne oth Enthalten in Elsevier Dou, Chao ELSEVIER Effects of shape functions on flexural–torsional buckling of fixed circular arches 2013 London [u.a.] (DE-627)ELV007685041 volume:383 year:2014 day:26 month:02 pages:26 https://doi.org/10.1016/S0140-6736(14)60289-0 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GEO 38.38 Seismologie VZ 56.20 Ingenieurgeologie Bodenmechanik VZ 56.11 Baukonstruktion VZ AR 383 2014 26 0226 26 383.2014, S26- 045F 610 |
| language |
English |
| source |
Enthalten in Effects of shape functions on flexural–torsional buckling of fixed circular arches London [u.a.] volume:383 year:2014 day:26 month:02 pages:26 |
| sourceStr |
Enthalten in Effects of shape functions on flexural–torsional buckling of fixed circular arches London [u.a.] volume:383 year:2014 day:26 month:02 pages:26 |
| format_phy_str_mv |
Article |
| bklname |
Seismologie Ingenieurgeologie Bodenmechanik Baukonstruktion |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Effects of shape functions on flexural–torsional buckling of fixed circular arches |
| authorswithroles_txt_mv |
Bluett, James @@aut@@ Morgan, Catharine @@oth@@ Thurston, Layla @@oth@@ Plant, Darren @@oth@@ Morgan, Ann @@oth@@ Wilson, Anthony @@oth@@ Isaacs, John @@oth@@ Hyrich, Kimme @@oth@@ Cordingley, Lis @@oth@@ Barton, Anne @@oth@@ |
| publishDateDaySort_date |
2014-01-26T00:00:00Z |
| hierarchy_top_id |
ELV007685041 |
| dewey-sort |
3610 |
| id |
ELV022395334 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV022395334</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623163825.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0140-6736(14)60289-0</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014002000011.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV022395334</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0140-6736(14)60289-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">690</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">38.38</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">56.20</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">56.11</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bluett, James</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Effect of inadequate adherence on clinical outcomes: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Anti-tumour necrosis factor (TNF) therapy has revolutionised patient prognosis in rheumatoid arthritis. In the UK, continuing anti-TNF therapy requires a sustained response as determined by the disease activity score in 28 joints (DAS28). Adherence to disease modifying anti-rheumatic drugs (DMARDs) is low but little is known about adherence to biological therapies and its association to treatment response. We investigated the association of adherence to subcutaneous anti-TNF therapy and DAS28 in people with rheumatoid arthritis.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Morgan, Catharine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thurston, Layla</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Plant, Darren</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Morgan, Ann</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wilson, Anthony</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Isaacs, John</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hyrich, Kimme</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cordingley, Lis</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Barton, Anne</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Dou, Chao ELSEVIER</subfield><subfield code="t">Effects of shape functions on flexural–torsional buckling of fixed circular arches</subfield><subfield code="d">2013</subfield><subfield code="g">London [u.a.]</subfield><subfield code="w">(DE-627)ELV007685041</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:383</subfield><subfield code="g">year:2014</subfield><subfield code="g">day:26</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:26</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0140-6736(14)60289-0</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GEO</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">38.38</subfield><subfield code="j">Seismologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">56.20</subfield><subfield code="j">Ingenieurgeologie</subfield><subfield code="j">Bodenmechanik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">56.11</subfield><subfield code="j">Baukonstruktion</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">383</subfield><subfield code="j">2014</subfield><subfield code="b">26</subfield><subfield code="c">0226</subfield><subfield code="h">26</subfield><subfield code="y">383.2014, S26-</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Bluett, James |
| spellingShingle |
Bluett, James ddc 610 ddc 690 bkl 38.38 bkl 56.20 bkl 56.11 Effect of inadequate adherence on clinical outcomes: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort |
| authorStr |
Bluett, James |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV007685041 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 690 - Buildings |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 690 VZ 38.38 bkl 56.20 bkl 56.11 bkl Effect of inadequate adherence on clinical outcomes: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort |
| topic |
ddc 610 ddc 690 bkl 38.38 bkl 56.20 bkl 56.11 |
| topic_unstemmed |
ddc 610 ddc 690 bkl 38.38 bkl 56.20 bkl 56.11 |
| topic_browse |
ddc 610 ddc 690 bkl 38.38 bkl 56.20 bkl 56.11 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
c m cm l t lt d p dp a m am a w aw j i ji k h kh l c lc a b ab |
| hierarchy_parent_title |
Effects of shape functions on flexural–torsional buckling of fixed circular arches |
| hierarchy_parent_id |
ELV007685041 |
| dewey-tens |
610 - Medicine & health 690 - Building & construction |
| hierarchy_top_title |
Effects of shape functions on flexural–torsional buckling of fixed circular arches |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV007685041 |
| title |
Effect of inadequate adherence on clinical outcomes: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort |
| ctrlnum |
(DE-627)ELV022395334 (ELSEVIER)S0140-6736(14)60289-0 |
| title_full |
Effect of inadequate adherence on clinical outcomes: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort |
| author_sort |
Bluett, James |
| journal |
Effects of shape functions on flexural–torsional buckling of fixed circular arches |
| journalStr |
Effects of shape functions on flexural–torsional buckling of fixed circular arches |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2014 |
| contenttype_str_mv |
zzz |
| container_start_page |
26 |
| author_browse |
Bluett, James |
| container_volume |
383 |
| class |
610 610 DE-600 690 VZ 38.38 bkl 56.20 bkl 56.11 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Bluett, James |
| doi_str_mv |
10.1016/S0140-6736(14)60289-0 |
| dewey-full |
610 690 |
| title_sort |
effect of inadequate adherence on clinical outcomes: results from the biologics in rheumatoid arthritis genetics and genomics study syndicate cohort |
| title_auth |
Effect of inadequate adherence on clinical outcomes: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort |
| abstract |
Anti-tumour necrosis factor (TNF) therapy has revolutionised patient prognosis in rheumatoid arthritis. In the UK, continuing anti-TNF therapy requires a sustained response as determined by the disease activity score in 28 joints (DAS28). Adherence to disease modifying anti-rheumatic drugs (DMARDs) is low but little is known about adherence to biological therapies and its association to treatment response. We investigated the association of adherence to subcutaneous anti-TNF therapy and DAS28 in people with rheumatoid arthritis. |
| abstractGer |
Anti-tumour necrosis factor (TNF) therapy has revolutionised patient prognosis in rheumatoid arthritis. In the UK, continuing anti-TNF therapy requires a sustained response as determined by the disease activity score in 28 joints (DAS28). Adherence to disease modifying anti-rheumatic drugs (DMARDs) is low but little is known about adherence to biological therapies and its association to treatment response. We investigated the association of adherence to subcutaneous anti-TNF therapy and DAS28 in people with rheumatoid arthritis. |
| abstract_unstemmed |
Anti-tumour necrosis factor (TNF) therapy has revolutionised patient prognosis in rheumatoid arthritis. In the UK, continuing anti-TNF therapy requires a sustained response as determined by the disease activity score in 28 joints (DAS28). Adherence to disease modifying anti-rheumatic drugs (DMARDs) is low but little is known about adherence to biological therapies and its association to treatment response. We investigated the association of adherence to subcutaneous anti-TNF therapy and DAS28 in people with rheumatoid arthritis. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GEO |
| title_short |
Effect of inadequate adherence on clinical outcomes: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort |
| url |
https://doi.org/10.1016/S0140-6736(14)60289-0 |
| remote_bool |
true |
| author2 |
Morgan, Catharine Thurston, Layla Plant, Darren Morgan, Ann Wilson, Anthony Isaacs, John Hyrich, Kimme Cordingley, Lis Barton, Anne |
| author2Str |
Morgan, Catharine Thurston, Layla Plant, Darren Morgan, Ann Wilson, Anthony Isaacs, John Hyrich, Kimme Cordingley, Lis Barton, Anne |
| ppnlink |
ELV007685041 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/S0140-6736(14)60289-0 |
| up_date |
2024-07-06T21:53:07.474Z |
| _version_ |
1803868215680434176 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV022395334</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623163825.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0140-6736(14)60289-0</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014002000011.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV022395334</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0140-6736(14)60289-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">690</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">38.38</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">56.20</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">56.11</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bluett, James</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Effect of inadequate adherence on clinical outcomes: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Anti-tumour necrosis factor (TNF) therapy has revolutionised patient prognosis in rheumatoid arthritis. In the UK, continuing anti-TNF therapy requires a sustained response as determined by the disease activity score in 28 joints (DAS28). Adherence to disease modifying anti-rheumatic drugs (DMARDs) is low but little is known about adherence to biological therapies and its association to treatment response. We investigated the association of adherence to subcutaneous anti-TNF therapy and DAS28 in people with rheumatoid arthritis.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Morgan, Catharine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thurston, Layla</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Plant, Darren</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Morgan, Ann</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wilson, Anthony</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Isaacs, John</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hyrich, Kimme</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cordingley, Lis</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Barton, Anne</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Dou, Chao ELSEVIER</subfield><subfield code="t">Effects of shape functions on flexural–torsional buckling of fixed circular arches</subfield><subfield code="d">2013</subfield><subfield code="g">London [u.a.]</subfield><subfield code="w">(DE-627)ELV007685041</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:383</subfield><subfield code="g">year:2014</subfield><subfield code="g">day:26</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:26</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0140-6736(14)60289-0</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GEO</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">38.38</subfield><subfield code="j">Seismologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">56.20</subfield><subfield code="j">Ingenieurgeologie</subfield><subfield code="j">Bodenmechanik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">56.11</subfield><subfield code="j">Baukonstruktion</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">383</subfield><subfield code="j">2014</subfield><subfield code="b">26</subfield><subfield code="c">0226</subfield><subfield code="h">26</subfield><subfield code="y">383.2014, S26-</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.3982153 |